News
FDA may permit Pfizer COVID vaccine for kids up to 5 years
Dr Anthony Fauci, the chief medical advisor to the White House has gone on to confirm that FDA might as well approve the Pfizer and the BioNTech vaccine for children less than 5 years starting in February 2022. Fauci...
Clinical Trials
Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant
Pfizer Inc. shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets), is maintained against the SARS-CoV-2 variant Omicron. Taken together, these...
News
Stempeutics gets DCGI nod for Phase 3 clinical trial on its product for treating COVID patients
Stempeutics, a group company of Manipal Education and Medical Group (MEMG) said it has received DCGI clearance to conduct Phase 3 clinical trial on its product for treating COVID-19 patients suffering from acute respiratory distress syndrome (ARDS).
The company will...
Drug Research
Lonza, Forbion, and BioGeneration Ventures Extend Collaboration to Add Development and Manufacturing Services of Small Molecules
Forbion, a leading venture capital firm building life sciences companies, BioGeneration Ventures (BGV), its joint venture partner and specialized life sciences venture capital firm focusing on early-stage European biotech companies, together with Lonza, a global development and manufacturing partner...
Drug Research
Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules
Abbisko Therapeutics Co., Ltd., a subsidiary of Abbisko Cayman Limited announced that it has entered into a worldwide collaboration and exclusive licensing agreement with Eli Lilly and Company for the further discovery, development and potential commercialization of novel molecules...
Clinical Trials
Catalent Launches New Xpress Pharmaceutics Service to Expedite Development of Oral Drugs for Adaptive Phase 1 Clinical Trials
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, announced the launch of its new Xpress Pharmaceutics™ service, designed to accelerate the...
News
Moderna to come up with combined Covid and flu booster by 2023
US drugmaker Moderna is working on a combined Covid-19 and flu booster shot, which could be available in some countries by fall 2023 at the earliest, CEO Stephane Bancel has said.
In his speech at the Davos Agenda, a virtual...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read